✦ LIBER ✦

Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

✍ Scribed by Shelby D. Reed; John J.V. McMurray; Eric J. Velazquez; Kevin A. Schulman; Robert M. Califf; Lars Kober; Aldo P. Maggioni; Frans Van de Werf; Harvey D. White; Rafael Diaz; Viatcheslav Mareev; Jan Murin

Book ID: 116190536
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 229 KB
Volume: 152
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2006.02.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-risk myocardial infarction in the y

High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

✍ Rachel E. Anderson; Marc A. Pfeffer; Jens Jakob Thune; John J.V. McMurray; Rober 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Fatal myocardial rupture after acute myo

Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)

✍ Faisal Shamshad; Satish Kenchaiah; Peter V. Finn; Jordi Soler-Soler; John J.V. M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Newly diagnosed and previously known dia

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: The VALsartan in Acute myocardial iNfarcTion (VALIANT) trial

✍ D. Aguilar; S.D. Solomon; L. Køber 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Usefulness of Beta Blockers in High-Risk

Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)

✍ Robert M. Califf; Yuliya Lokhnygina; Eric J. Velazquez; John J.V. McMurray; Jeff 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 617 KB

Seasonal variation in acute myocardial i

Seasonal variation in acute myocardial infarction

✍ Tsung O. Cheng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Resource use, costs, and quality of life

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

✍ Shelby D. Reed; Jasmina I. Radeva; Kevin P. Weinfurt; John J.V. McMurray; Marc A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 390 KB